As of 2025-07-19, the Relative Valuation of InMed Pharmaceuticals Inc (IN.TO) is (15.76) CAD. This relative valuation is based on P/E multiples. With the latest stock price at 4.19 CAD, the upside of InMed Pharmaceuticals Inc based on Relative Valuation is -476.2%.
The range of the Relative Valuation is (15.35) - (18.17) CAD.
Note: valuation result may not be accurate due to the company's negative earnings.
Range | Selected | |
Trailing P/E multiples | 7.2x - 13.3x | 9.0x |
Forward P/E multiples | 11.2x - 17.3x | 14.0x |
Fair Price | (15.35) - (18.17) | (15.76) |
Upside | -466.4% - -533.7% | -476.2% |
Date | P/E |